IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

TRV GP II, LLC

Q3 2018 Holdings

Filed 2018-10-29 | 4 holdings | $170.4K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Blueprint Medicines Corporation(2L9)COM09627Y109$68.6K878,87540.3%
Jounce Therapeutics, Inc.(JNCEEUR)COM481116101$66.5K10,230,34939.0%
Allena Pharmaceuticals, Inc.(ALNAEUR)COM018119107$30.0K2,790,96417.6%
Sage Therapeutics, Inc.(SG7)COM78667J108$5.3K37,3623.1%